GKB vs Lotus Pharm: monthly revenue

Monthly revenue and year-on-year change for GKB (1707) and Lotus Pharm (1795) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ GKB ━ Lotus Pharm

0%+226%-31%25/1026/0126/0426/0726/10

Monthly revenue history

MonthGKBYoYLotus PharmYoY
Oct 2026NT$748.3 million-30.8%NT$2.13 billion-22.5%
Sep 2026NT$726.3 million-7.9%NT$2.77 billion+128.0%
Aug 2026NT$706.1 million-20.1%NT$2.11 billion+81.7%
Jul 2026NT$716.7 million-5.1%NT$2.49 billion+3.9%
Jun 2026NT$819.6 million-7.2%NT$3.4 billion+225.5%
May 2026NT$787.6 million-4.8%NT$2.32 billion+105.8%
Apr 2026NT$806.4 million-6.0%NT$3.09 billion+19.9%
Mar 2026NT$857.7 million-7.0%NT$4.35 billion+173.6%
Feb 2026NT$625.8 million-1.3%NT$2.24 billion+131.5%
Jan 2026NT$794.5 million+14.1%NT$2.05 billion-5.5%
Dec 2025NT$829.4 million-30.4%NT$2.44 billion+66.9%
Nov 2025NT$1.09 billion+0.8%NT$1.06 billion-0.2%
Oct 2025NT$1.08 billion+22.9%NT$2.75 billion+46.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16